Skip to content

rTMS in Spastic Hemiplegic Cerebral Palsy Children

The Role of Repetitive Transcranial Magnetic Stimulation in Spastic Hemiplegic Cerebral Palsy in a Sample of Egyptian Children

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05134259
Enrollment
60
Registered
2021-11-24
Start date
2022-01-01
Completion date
2022-08-01
Last updated
2022-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

cerebral palsy

Brief summary

The aim of the work is to study the role of repetitive transcranial magnetic stimulation (rTMS) in spastic hemiplegic cerebral palsy in a Sample of Egyptian Children.

Detailed description

Prior to start of rTMS therapy, Gross Motor Function Classification System (GMFCS) will be employed on the participants to classify gross motor function. Also, Modified Ashworth Scale (MAS) scoring will be employed on the participants to access spasticity on selected muscles namely, hamstring, soleus, gastrocnemius and adductor of lower limb; and bicep, supinator and wrist extensor of upper limb. rTMS frequency of 10 Hz will be delivered to each of the participants in the study group for 15 minutes per session. Each session will be administered once daily for 2 days a week for 4 weeks. 1500 pulses (50 pulses per train with total 30 trains having inter- train delay of 25 seconds) per session will be provided with the coil placed on the contralateral primary motor cortex (M1) which is known to produce modulatory effect on muscle tightness of the limbs (Rajak et al. 2017). rTMS frequency of 10 Hz was kept constant based on previous studies with 5 Hz and 10 Hz (Anttila et al. 2008) (Rossi 2009). Each session will be followed by physical therapy (PT) according to physiotherapy protocol. After completion of therapeutic programs (after 4 weeks), the participants will be asked to undergo post assessment of Gross Motor Function Classification System (GMFCS), and Modified Ashworth Scale (MAS) scoring on exactly the same muscles as recorded previously. Both PT and rTMS sessions will be administered by trained professionals who was kept blinded to the research protocols used in the study.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

TMS device will deliver repetitive trains of magnetic pulses using Magstim Rapid 2 with angulated figure of eight shaped coil. The device comprised two-channel Neuro-EMG-MS digital system for determining the motor threshold of the patients that will be used for establishing the threshold intensity for stimulation. The figure of eight-shaped coil generated a magnetic field of up to 4 Tesla that penetrates the cranium, enters into the soft tissue of the brain and henceforth stimulates the motor neurons.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Willingness to participate. 2. Age group between 4 and 18 years. 3. They are able to walk with limitation or holding on according to Gross Motor Function classification System (GMFCS) (level II, III, IV). 4. All patients have mild to moderate spasticity according to modified Ashworth scale (Grade 1, 1+,2).

Exclusion criteria

* All Children with: 1. Perceptual defects (IQ\<70). 2. Use of botulinum toxin in the past 4 months. 3. Convulsions. 4. Other peripheral or central nervous system dysfunction. 5. Fixed deformities in lower limbs. 6. Clinically suspected active inflammatory or pathologic changes in lower limb joints during the previous 6 months. 7. Clinically suspected active medical problems, such as pneumonia, meningitis, encephalitis, upper gastrointestinal bleeding, or urinary tract infection. 8. Metabolic disorders, such as inborn error of metabolism, electrolyte, and endocrine disorders. 9. Metallic implants.

Design outcomes

Primary

MeasureTime frameDescription
Change in muscle spasticity1 week following end of treatmentAssessment tools: Modified Ashworth Scale. It grades muscle spasticity between 0 to 4. Higher score mean a worse outcome.

Secondary

MeasureTime frameDescription
Change in gross motor function1 week following end of treatmentGross Motor Function Classification System (GMFCS). It includes five levels and four age bands. Classifications are made based on the child's self-initiated movements with emphasis on sitting and walking. Higher score mean a worse outcome.

Countries

Egypt

Contacts

Primary ContactAhmed A. Muhammad
ahmed.a.muh@gmail.com0201093444878
Backup ContactAbdel-Ghaffar I. Fayed, Lecturer
drfayed1984@azhar.edu.eg0201018059585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026